Literature DB >> 9225823

Decreased substance P content in the rectal mucosa of diabetics with diarrhea and constipation.

J Lysy1, F Karmeli, M Sestieri, Y Yatzkan, E Goldin.   

Abstract

Substance P (SP), vasoactive intestinal polypeptide (VIP), and somatostatin content in rectal mucosa were determined by radioimmunoassay (RIA) in 38 diabetic patients (12 with normal bowel function, 13 with diabetic diarrhea, and 13 with constipation) and in 10 nondiabetic controls with normal bowel function. SP content (picograms per milligram) in the rectal mucosa of diabetics with normal bowel function was significantly higher than that of nondiabetic controls (P < .05). SP content in the rectal mucosa of diabetics with diabetic diarrhea and constipation was significantly lower than in diabetics with normal bowel habits and nondiabetic controls (P < .05). No differences were found in the rectal mucosa content of VIP and somatostatin between the different groups of diabetics and controls. Diabetic diarrhea is a condition with an intermittent nature and frequently alternates with constipation. Our findings showing low levels of rectal mucosa SP in both conditions suggest a possible common role of SP in the pathogenesis of diabetic diarrhea and constipation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225823     DOI: 10.1016/s0026-0495(97)90114-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

Review 1.  Diabetes and the enteric nervous system.

Authors:  B Chandrasekharan; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2007-10-17       Impact factor: 3.598

Review 2.  Adult constipation: a review and clinical guide.

Authors:  T Q Jacobs; R J Pamies
Journal:  J Natl Med Assoc       Date:  2001-01       Impact factor: 1.798

3.  Effects of sEA on Slow Transit Constipation through the Microbiota-Gut-Brain Axis in Rats.

Authors:  Xun Jin; Yanting Guan; Hua Bai; Yan Liu; Xing Lv
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-14       Impact factor: 2.629

4.  CNS-Sparing Histamine H3 Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms.

Authors:  Arianna Carolina Rosa; Patrizia Nardini; Silvia Sgambellone; Maura Gurrieri; Simona Federica Spampinato; Alfonso Dell'Accio; Paul L Chazot; Ilona Obara; Wai L Liu; Alessandro Pini
Journal:  Biomolecules       Date:  2022-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.